pifithrin has been researched along with Muscular Dystrophy, Oculopharyngeal in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
Muscular Dystrophy, Oculopharyngeal: An autosomal dominant hereditary disease that presents in late in life and is characterized by DYSPHAGIA and progressive ptosis of the eyelids. Mutations in the gene for POLY(A)-BINDING PROTEIN II have been associated with oculopharyngeal muscular dystrophy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharjee, RB | 1 |
| Zannat, T | 1 |
| Bag, J | 1 |
1 other study available for pifithrin and Muscular Dystrophy, Oculopharyngeal
| Article | Year |
|---|---|
Expression of the polyalanine expansion mutant of nuclear poly(A)-binding protein induces apoptosis via the p53 pathway.
Topics: Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Benzothiazoles; Caspase 3; Cyt | 2012 |